FIIs increased their stake in Piramal Pharma to 30.17% in March 2026 from 29.66% in December 2025, while DIIs reduced holdings to 15.61%. The stock witnessed trading volume of more than 8x its 20-day average and has gained 10.31% over the past year. Market capitalisation stands at ₹23,219 crore.